Shire Sues Cadila Healthcare
The lawsuit was filed as a result of an abbreviated new drug application (ANDA) filed by Zydus seeking FDA approval to market and sell generic versions of Lialda
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.